July 13, 2009 - The new ProCure Proton Therapy Center in Oklahoma City celebrated its official grand opening on July 8, 2009, where patients with head and neck, brain, central nervous system, prostate and some pediatric cancers will be treated at the new Center

The center is the first in a network of ProCure centers, which treat patient with proton therapy, to open across the country. ProCure has a second center under construction in the suburbs of Chicago, scheduled to open in early 2011; and centers in development in New Jersey, south Florida and Detroit, Mich.

According to Procure Inc., there is a need for protons that is not accommodated for, as an estimated 250,000 patients could benefit from proton therapy annually while only 6,000 treatment slots are available through the five centers that have been operating to date.

The Procure Proton Therapy Center in Oklahoma City is affiliated with INTEGRIS Health, the largest Oklahoma-owned, not-for-profit health system in the state. INTEGRIS is opening the cancer institute adjacent to the proton therapy Center and will provide treatment and services to patients who may need additional care while undergoing proton therapy.

The 60,000-square-foot center will have four treatment rooms with a treatment capacity of 1,500 patients a year. Patients will be chosen according to medical appropriateness and evaluated by a physician review board. Patients under treatment will have personal care teams of medical professionals who will remain with them throughout their treatment. The team will involve patients’ personal physicians to allow for a continuum of care.

For more information: www.procure.com


Related Content

News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
Subscribe Now